Literature DB >> 23510905

Early fluid resuscitation with hypertonic solution in a rat crush injury model.

Xiao-Bing Song1, Xian-Long Zhou, Shao-Zhou Ni, Gui-Fang Yang, Su-Fang Tian, Jiang Shan, Yan Zhao, Jun Shen, Xiang Wang.   

Abstract

AIM OF THE STUDY: The aim of the study was to evaluate the effects of bolus infusion of hypertonic hydroxyethyl starches (HHESs) and continuous infusion of hypertonic saline (HTS) in the early resuscitation in crush syndrome.
METHODS: A rat model of crush injury was established. Rats were randomly divided into five groups: (1) HHES group, (2) HTS group, (3) volume resuscitation group, (4) normal resuscitation (NR) group, and (5) sham group. Blood samples were collected 6 h after the crush period for biochemical evaluation. Blood pressure was monitored throughout this experiment. Muscles and kidneys were evaluated morphologically 24 h after reperfusion. Twenty rats in each group were taken for survival observation for 72 h.
RESULTS: Compared with the NR and HTS groups, the HHES group had significantly increased the survival rate 72 h after release (P < 0.05). In the first 2 h after release, mean arterial blood pressure in the HHES group was significantly higher than in HTS, volume resuscitation, and NR groups (respectively, P < 0.05). Animals that received HHES infusion showed a better acid-base balance and renal function. However, there was no significant difference in survival rate between the HTS and NR groups. Furthermore, animals in the HTS group showed a bad acid-base balance and a higher serum sodium level.
CONCLUSIONS: Bolus infusion of HHES combined with normal saline could be an effective therapy for crush syndrome in the early resuscitation period. However, continuous HTS injection was not seemed to be a suitable choice particularly in the absence of monitoring equipment for serum irons or blood gases (institutional protocol no. ZN5R20110016).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510905     DOI: 10.1097/SHK.0b013e31828e674a

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  3 in total

1.  Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway.

Authors:  Bin-Fei Zhang; Peng-Fei Wang; Yu-Xuan Cong; Jin-Lai Lei; Hu Wang; Hai Huang; Shuang Han; Yan Zhuang
Journal:  J Orthop Surg Res       Date:  2017-07-12       Impact factor: 2.359

Review 2.  Emerging medical therapies in crush syndrome - progress report from basic sciences and potential future avenues.

Authors:  Ning Li; Xinyue Wang; Pengtao Wang; Haojun Fan; Shike Hou; Yanhua Gong
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

3.  Comparison of the effects of volemic reposition with 7.5% NaCl or blood in an experimental model of muscular compression and hemorrhagic shock.

Authors:  Mauricio Wanderley Moral Sgarbi; Bomfim Alves Silva Júnior; Daniel de Almeida Pires; Irineu Tadeu Velasco
Journal:  Rev Bras Ortop       Date:  2018-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.